HIGHLIGHTED
PROJECTS
Tracing Salmonella transmission in The Philippines
PAST PROJECTS
Analysis of Klebsiella pneumoniae from Portuguese hospitals reveals insights into circulating amr
Genomic analysis of hypervirulent Klebsiella pneumoniae reveals potential genetic markers
Genomic analysis of global Klebsiella pneumoniae plasmids
Methylation analysis of Klebsiella pneumoniae from Portuguese hospitals
A phylogenomic approach for the analysis of colistin resistance-associated genes in Klebsiella pneumoniae
Extended-spectrum beta-lactam and carbapenem-resistant Klebsiella pneumoniae polyclonal outbreak
Genomic Epidemiology of Carbapenemase Producing Klebsiella pneumoniae Strains Enables the Detection of a Misidentified Klebsiella variicola KPC-3
Tracing MRSA Transmission
Tracing Salmonella transmission in The Philippines
Salmonellosis, caused by Salmonella, is among the most frequently reported foodborne diseases worldwide, including in the Philippines. While numerous potential means of transmission exist, commercial chicken and pig meat has been identified as one of the most important food vehicles for these organisms. Treatment options for salmonellosis are decreasing as the underlying bacteria continue to show resistance to antimicrobial drugs. Multi-drug resistant isolates of Salmonella are present in the Philippines. To fully understand transmission dynamics and virulence across the food chains requires the genomic characterisation of isolates. Whole-genome sequencing (WGS) technology has become a fast and affordable tool that is revolutionizing the fields of genetics, microbiology, and ecology, as well as public health surveillance and response. WGS analysis can potentially be a rapid and cost-effective approach to define resistance genotypes, predict resistance phenotypes and identify identical isolate genomes that are part of a transmission chains. Across domains in the food chain in Manilla and Pampanga, including markets and retailers, we propose to test poultry and swine meat for Salmonella, and sequence the pathogens. We will build phylogenies and compare inferred phenotypes to laboratory determined virulence and drug resistance outcomes.
People who worked on this project:
tgclark
troberts
Analysis of Klebsiella pneumoniae from Portuguese hospitals reveals insights into circulating amr
Klebsiella pneumoniae (Kp) bacteria are an increasing threat to public health and represent one of the most concerning pathogens involved in life-threatening infections and antimicrobial resistance (AMR). To understand the epidemiology of AMR of Kp in Portugal, we analysed whole genome sequencing, susceptibility testing and other meta data on 509 isolates collected nationwide from 16 hospitals and environmental settings between years 1980 and 2019. Predominant sequence types (STs) included ST15 (n = 161, 32%), ST147 (n = 36, 7%), ST14 (n = 26, 5%) or ST13 (n = 26, 5%), while 31% of isolates belonged to STs with fewer than 10 isolates. AMR testing revealed widespread resistance to aminoglycosides, fluoroquinolones, cephalosporins and carbapenems. The most common carbapenemase gene was blaKPC-3. Whilst the distribution of AMR linked plasmids appears uncorrelated with ST, their frequency has changed over time. Before year 2010, the dominant plasmid group was associated with the extended spectrum beta-lactamase gene blaCTX-M-15, but this group appears to have been displaced by another carrying the blaKPC-3 gene. Co-carriage of blaCTX-M and blaKPC-3 was uncommon. Our results from the largest genomics study of Kp in Portugal highlight the active transmission of strains with AMR genes and provide a baseline set of variants for future resistance monitoring and epidemiological studies.
People who worked on this project:
aspadar
jphelan
tgclark
scampino
Genomic analysis of hypervirulent Klebsiella pneumoniae reveals potential genetic markers
The majority of Klebsiella pneumoniae (Kp) infections are nosocomial, but a growing number of community-acquired infections are caused by hypervirulent strains (hvKp) characterised by liver invasion and rapid metastasis. Unlike nosocomial Kp infections, hvKp are generally susceptible to antibiotics. Due to the rapid progression of hvKp infections, timely and accurate diagnosis is required for effective treatment. To identify potential drivers of the hypervirulent phenotype, we performed a genome-wide association study (GWAS) analysis on single nucleotide variants and accessory genome loci across 79 publicly available Kp isolates collected from patients’ liver and a diverse global Kp dataset (n = 646). The GWAS analysis revealed 29 putative genes (P < 10–10) associated with higher risk of liver phenotype, including hypervirulence linked salmochelin iro (odds ratio (OR): 29.8) and aerobactin iuc (OR: 14.1) loci. A minority of liver isolates (n = 15, 19%) had neither of these siderophores nor any other shared biomarker, suggesting possible unknown drivers of hypervirulence and an intrinsic ability of Kp to invade the liver. Despite identifying potential novel loci linked to a liver invasive Kp phenotype, our work highlights the need for large-scale studies involving more sequence types to identify further hypervirulence biomarkers to assist clinical decision making.
People who worked on this project:
aspadar
tgclark
scampino
Genomic analysis of global Klebsiella pneumoniae plasmids
We identified and analysed 3034 unique plasmid replicons to inform the epidemiology and transmission dynamics of carbapenem-resistant hypervirulent Klebsiella pneumoniae (Kp) (n=1028, 7.8%). We found several outbreaks globally, including one involving ST11 strains in China and another of ST231 in Asia centred on India, Thailand, and Pakistan. There was evidence of global flow of Kp, including across multiple continents. In most cases, clusters of Kp isolates are the result of hypervirulence genes entering classic strains, instead of carbapenem resistance genes entering canonical hypervirulent onesg.
People who worked on this project:
aspadar
tgclark
scampino
Methylation analysis of Klebsiella pneumoniae from Portuguese hospitals
Klebsiella pneumoniae is an important nosocomial infectious agent with a high antimicrobial resistance (AMR) burden. The application of long read sequencing technologies is providing insights into bacterial chromosomal and putative extra-chromosomal genetic elements (PEGEs) associated with AMR, but also epigenetic DNA methylation, which is thought to play a role in cleavage of foreign DNA and expression regulation. Here, we apply the PacBio sequencing platform to eight Portuguese hospital isolates, including one carbapenemase producing isolate, to identify methylation motifs. The resulting assembled chromosomes were between 5.2 and 5.5Mbp in length, and twenty-six PEGEs were found. Four of our eight samples carry blaCTX-M-15, a dominant Extended Spectrum Beta Lactamase in Europe. We identified methylation motifs that control Restriction–Modification systems, including GATC of the DNA adenine methylase (Dam), which methylates N6-methyladenine (m6A) across all our K. pneumoniae assemblies. There was a consistent lack of methylation by Dam of the GATC motif downstream of two genes: fosA, a locus associated with low level fosfomycin resistance, and tnpB transposase on IncFIB(K) plasmids. Overall, we have constructed eight high quality reference genomes of K. pneumoniae, with insights into horizontal gene transfer and methylation m6A motifs.
People who worked on this project:
aspadar
tgclark
scampino
A phylogenomic approach for the analysis of colistin resistance-associated genes in Klebsiella pneumoniae
The emergence of carbapenemase-producing Klebsiella pneumoniae strains has triggered the use of old antibiotics such as colistin. This is driving the emergence of colistin resistance in multidrug-resistant strains that underlie life-threatening infections. This study analyses the mutational diversity of 22 genes associated with colistin resistance in 140 K. pneumoniae clinical isolates integrated in a high-resolution phylogenetic scenario. Colistin susceptibility was accessed by broth microdilution. A total of 98 isolates were susceptible and 16 were resistant, 10 of which were carbapenemase producers. Across the 22 genes examined, 171 non-synonymous mutations and 9 mutations associated with promoter regions were found. Eighty-five isolates had a truncation and/or deletion in at least one of the 22 genes. However, only seven mutations, the complete deletion of mgrB or insertion sequence (IS)-mediated disruption, were exclusively observed in resistant isolates. Four of these (mgrB Ile13fs, pmrB Gly207Asp, phoQ His339Asp and ramA Ile28Met) comprised novel mutations that are potentially involved in colistin resistance. One strain bore a ISEcp1-blaCTX-M-15::mgrB disruption, underlying co-resistance to third-generation cephalosporins and colistin. Moreover, the high-resolution phylogenetic context shows that most of the mutational diversity spans multiple phylogenetic clades, and most of the mutations previously associated with colistin resistance are clade-associated and present in susceptible isolates, showing no correlation with colistin resistance.
People who worked on this project:
aspadar
jphelan
tgclark
scampino
Extended-spectrum beta-lactam and carbapenem-resistant Klebsiella pneumoniae polyclonal outbreak
Klebsiella pneumoniae has emerged as an important nosocomial pathogen, with whole-genome sequencing (WGS) significantly improving our ability to characterize associated outbreaks. Our study sought to perform a genome-wide analysis of multiclonal K. pneumoniae isolates (n=39; 23 patients) producing extended spectrum beta-lactamases and/or carbapenemases sourced between 2011 and 2016 in a Portuguese tertiary-care hospital. All isolates showed resistance to third-generation cephalosporins and six isolates (five patients) were also carbapenem resistant. Genome-wide-based phylogenetic analysis revealed a topology representing ongoing dissemination of three main sequence-type (ST) clades (ST15, ST147 and ST307) and transmission across different wards, compatible with missing links that can take the form of undetected colonized patients. Two carbapenemase-coding genes were detected: blaKPC-3, located on a Tn4401d transposon, and blaGES-5 on a novel class 3 integron. Additionally, four genes coding for ESBLs (blaBEL-1, blaCTX-M-8, blaCTX-M-15 and blaCTX-M-32) were also detected. ESBL horizontal dissemination across five clades is highlighted by the similar genetic environments of blaCTX-M-15 gene upstream of ISEcp1 on a Tn3-like transposon. Overall, this study provides a high-resolution genome-wide perspective on the epidemiology of ESBL and carbapenemase-producing K. pneumoniae in a healthcare setting while contributing for the adoption of appropriate intervention and prevention strategies.
People who worked on this project:
aspadar
jphelan
tgclark
scampino
Genomic Epidemiology of Carbapenemase Producing Klebsiella pneumoniae Strains Enables the Detection of a Misidentified Klebsiella variicola KPC-3
The evolutionary epidemiology, resistome, virulome and mobilome of thirty-one multidrug resistant Klebsiella pneumoniaee clinical isolates from the northern Vila Real region of Portugal were characterized using whole-genome sequencing and bioinformatic analysis. The genomic population structure was dominated by two main sequence types (STs): ST147 (n = 17; 54.8%) and ST15 (n = 6; 19.4%) comprising four distinct genomic clusters. Two main carbapenemase coding genes were detected (blaKPC-3 and blaOXA-48) along with additional extended-spectrum β-lactamase coding loci (blaCTX-M-15, blaSHV-12, blaSHV-27, and blaSHV-187). Moreover, whole genome sequencing enabled the identification of one Klebsiella variicola KPC-3 producer isolate previously misidentified as K. pneumoniae, which in addition to the blaKPC-3 carbapenemase gene, bore the chromosomal broad spectrum β-lactamase blaLEN-2 coding gene, oqxAB and fosA resistance loci. The blaKPC-3 genes were located in a Tn4401b transposon (K. variicola n = 1; K. pneumoniae n = 2) and Tn4401d isoform (K. pneumoniae n = 28). Overall, our work describes the first report of a blaKPC-3 producing K. variicola, as well as the detection of this species during infection control measures in surveillance cultures from infected patients. It also highlights the importance of additional control measures to overcome the clonal dissemination of carbapenemase producing clones.
People who worked on this project:
aspadar
jphelan
tgclark
scampino
Tracing MRSA Transmission
Recent evidence suggests hospital transmission of methicillin-resistant Staphylococcus aureus (MRSA) is uncommon in UK centres that have implemented sustained infection control programmes. We investigated whether a healthcare-network analysis could shed light on transmission paths currently sustaining MRSA levels in UK hospitals. A cross-sectional observational study was performed in two NHS hospital groups and a general district hospital in South-East London. All MRSA patients identified at inpatient, outpatient and community settings between 1st November 2011 and 29th February 2012 were included. We identified genetically-defined MRSA transmission clusters in individual hospitals and across the healthcare-network, and examined genetic differentiation of ST22 MRSA isolates within and between hospitals and inpatient or outpatient and community settings, as informed by average and median pairwise single nucleotide polymorphisms (SNPs) and SNP-based proportions of nearly identical isolates. 248/610 (40.7%) MRSA patients were linked in 90 transmission-clusters, of which 27 spanned multiple hospitals. Analysis of a large 32 patient ST22-MRSA cluster showed that 26/32 patients (81·3%) had multiple contacts with one another during ward stays at any hospital. No residential, outpatient or significant community healthcare contacts were identified. Genetic differentiation between ST22 MRSA inpatient isolates from different hospitals was less than between inpatient isolates from the same hospitals (p ≤ 0.01). Overall, there is evidence of frequent ward-based transmission of MRSA brought about by frequent patient admissions to multiple hospitals. Limiting in-ward transmission requires sharing of MRSA-status data between hospitals. This work was in partnership with Jonathan Edgeworth (KCL), and is now published
People who worked on this project:
tgclark